Related Experiment Video
Updated: Jul 17, 2026

Transretinal ERG Recordings from Mouse Retina: Rod and Cone Photoresponses
Published on: March 14, 2012
The review of the RoHS Directive
1European Diagnostic Manufacturers Association, Brussels, Belgium. k.howes@edma-ivd.be
Insights
The Restriction of Hazardous Substances (RoHS) Directive may soon apply to in vitro diagnostic (IVD) medical devices. This review explores the potential impact on the IVD industry.
Area of Science:
- Medical Device Regulation
- Environmental Health and Safety
Background:
- The Restriction of Hazardous Substances (RoHS) Directive currently exempts in vitro diagnostic (IVD) medical devices.
- A review of this exemption is underway, potentially altering regulatory requirements for IVDs.
Framework:
- Analysis of the current RoHS Directive and its scope.
- Examination of the regulatory review process concerning IVD medical devices.
Implementation:
- Assessing the potential inclusion of IVDs within the RoHS regulatory framework.
- Identifying specific hazardous substances and their relevance to IVD manufacturing.
Implications:
- Evaluating the impact of RoHS compliance on IVD product design, manufacturing, and supply chains.
- Discussing potential challenges and opportunities for the IVD industry under new regulations.
- Considering the effect on global market access and regulatory harmonization for IVD devices.
Abstract:
The Directive on the Restriction of Hazardous Substances currently excludes in vitro diagnostic (IVD) medical devices from its scope. That exemption is being reviewed. This article examines the implications of this for the IVD industry.
Related Concept Videos
The Retina
Channel Rhodopsins
Rhodopsins belong to the family of cell surface proteins called G-protein coupled receptors,...
Anatomy of the Eyeball
Drug Regulation
Drug Control Governance: Regulatory Bodies and Their Impact
Photoreceptors and Visual Pathways
